Bridgewater, NJ, November 2, 2018 – Nipro Medical Corporation announced the launch of Cellentia®-H cellulose triacetate (CTA), single-use dialyzer at the 2017 ASN Kidney Week Conference. The Cellentia®-H is the newest addition to Nipro’s growing line of high performance dialyzers. The Cellentia®-H dialyzer is indicated for all hemodialysis patients, especially those where conservative therapy is.. read more →

Bridgewater, New Jersey – April 22, 2016: Nipro North America, a division of Nipro Medical Corporation, announced the launch of the SafeTouch Safety Needle, featuring an easy to use anti-needlestick safety design. The SafeTouch Safety Needle is the newest addition to Nipro’s portfolio of Medical-Surgical device offerings. “Nipro has been providing quality needles for over.. read more →

Bridgewater, New Jersey – February 19, 2016: Nipro North America, a division of Nipro Medical Corporation, announced the launch of the Cronus HP high-pressure, 0.035” over-the-wire (OTW) percutaneous transluminal angioplasty (PTA) balloon catheter. Cronus HP is indicated for percutaneous transluminal angioplasty in the femoral, popliteal, iliac and renal arteries and for the treatment of obstructive.. read more →

Bridgewater, New Jersey – February 18, 2016: Nipro North America, a division of Nipro Medical Corporation, announced the launch of the AQUALiner II 0.035” second generation hydrophilic, super-elastic Nitinol guidewire. The guidewire enables the operator to navigate through complex lesions and deliver interventional devices such as balloons and stents. The reengineered AQUALiner II is the.. read more →

Bridgewater, New Jersey – July 10, 2015: Nipro Medical Corporation, a subsidiary for North & South America Sales and Marketing of Nipro Corporation, announced at the 2015 AVMA Convention, the launch of Nipro VSmart products dedicated to the veterinary market. Nipro is a leading manufacturer of medical devices with a good presence in the pet.. read more →

Global leadership in design and manufacturing targets better dialysis patient outcomes for U.S. market Bridgewater, New Jersey – November 11, 2014: Nipro Medical Corporation, a subsidiary for North & South America Sales and Marketing of Nipro Corporation in Japan, a world leader in dialyzer design and manufacturing, announced at Kidney Week 2014, the launch of the.. read more →

Bridgewater, New Jersey – May 7, 2014: Nipro Medical Corporation, headquarters for North & South America Sales and Marketing for Nipro Corporation in Japan, a world leader in dialyzer design and manufacturing, has relocated the Sales, Marketing and Customer Service operations from Miami, FL to Bridgewater, NJ. The office in Miami will continue to support the Latin.. read more →

Global leadership in design and manufacturing targets better dialysis patient outcomes for U.S. market Miami, Florida – February 6, 2014: Nipro Medical Corporation, a subsidiary for North & South America Sales and Marketing of Nipro Corporation in Japan, a world leader in dialyzer design and manufacturing, today announced the introduction of the ELISIO™ Polynephron™ Single.. read more →

Nipro Medical Corporation has launched its new website http://niproadmin.wpengine.com. The new website is designed to provide a user-friendly experience with improved navigation and functionality throughout, allowing current and potential customers to access detailed product and services information and a complete library of related resources. The new design is also a first step in Nipro’s rebranding.. read more →

Nipro Medical Corporation participated at the 2013 Association on Nephrology Nurses’ Association’s conference, which took place on April 21-24 at the Rio Hotel in Las Vegas. Over 1,000 nephrology professionals participated in this 3-day event. Conference activities included educational and networking sessions as well as an extensive display of the latest renal products and technology… read more →